Literature DB >> 19336447

Variable slope normalization of reverse phase protein arrays.

E Shannon Neeley1, Steven M Kornblau, Kevin R Coombes, Keith A Baggerly.   

Abstract

MOTIVATION: Reverse phase protein arrays (RPPA) measure the relative expression levels of a protein in many samples simultaneously. A set of identically spotted arrays can be used to measure the levels of more than one protein. Protein expression within each sample on an array is estimated by borrowing strength across all the samples, but using only within array information. When comparing across slides, it is essential to account for sample loading, the total amount of protein printed per sample. Currently, total protein is estimated using either a housekeeping protein or the sample median across all slides. When the variability in sample loading is large, these methods are suboptimal because they do not account for the fact that the protein expression for each slide is estimated separately.
RESULTS: We propose a new normalization method for RPPA data, called variable slope (VS) normalization, that takes into account that quantification of RPPA slides is performed separately. This method is better able to remove loading bias and recover true correlation structures between proteins. AVAILABILITY: Code to implement the method in the statistical package R and anonymized data are available at (http://bioinformatics.mdanderson.org/supplements.html).

Mesh:

Year:  2009        PMID: 19336447      PMCID: PMC3968550          DOI: 10.1093/bioinformatics/btp174

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  31 in total

Review 1.  Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays.

Authors:  Lu Charboneau; Heather Tory; Heather Scott; Tina Chen; Mary Winters; Emanuel F Petricoin; Lance A Liotta; Cloud P Paweletz
Journal:  Brief Funct Genomic Proteomic       Date:  2002-10

Review 2.  Protein microarray detection strategies: focus on direct detection technologies.

Authors:  Virginia Espina; Elisa C Woodhouse; Julia Wulfkuhle; Heather D Asmussen; Emanuel F Petricoin; Lance A Liotta
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

3.  Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.

Authors:  Christian Gulmann; Virginia Espina; Emanuel Petricoin; Dan L Longo; Mariarita Santi; Turid Knutsen; Mark Raffeld; Elaine S Jaffe; Lance A Liotta; Andrew L Feldman
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

4.  Robust estimation of protein expression ratios with lysate microarray technology.

Authors:  Cristian Mircean; Ilya Shmulevich; David Cogdell; Woonyoung Choi; Yu Jia; Ioan Tabus; Stanley R Hamilton; Wei Zhang
Journal:  Bioinformatics       Date:  2005-01-12       Impact factor: 6.937

Review 5.  Diagnostic challenges for multiplexed protein microarrays.

Authors:  Stephen R Master; Charlene Bierl; Larry J Kricka
Journal:  Drug Discov Today       Date:  2006-09-26       Impact factor: 7.851

6.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

Review 7.  Clinical proteomics: new trends for protein microarrays.

Authors:  K-F Becker; V Metzger; S Hipp; H Höfler
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

8.  Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray.

Authors:  M Akkiprik; D Nicorici; D Cogdell; Y J Jia; A Hategan; I Tabus; O Yli-Harja; D Y; A Sahin; W Zhang
Journal:  Technol Cancer Res Treat       Date:  2006-12

9.  Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.

Authors:  Rongcai Jiang; Cristian Mircean; Ilya Shmulevich; David Cogdell; Yu Jia; Ioan Tabus; Kenneth Aldape; Raymond Sawaya; Janet M Bruner; Gregory N Fuller; Wei Zhang
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

Review 10.  Protein microarrays: a chance to study microorganisms?

Authors:  Jürgen Kreutzberger
Journal:  Appl Microbiol Biotechnol       Date:  2006-02-18       Impact factor: 4.813

View more
  52 in total

1.  Reno: regularized non-parametric analysis of protein lysate array data.

Authors:  Bin Li; Feng Liang; Jianhua Hu; And Xuming He
Journal:  Bioinformatics       Date:  2012-03-30       Impact factor: 6.937

2.  Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.

Authors:  Bing Z Carter; Yihua Qiu; Xuelin Huang; Lixia Diao; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Marina Konopleva; Jorge Cortes; Hagop M Kantarjian; Gordon B Mills; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2012-05-29       Impact factor: 22.113

3.  The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Rodrigo Jacamo; Jared K Burks; Zhihong Zeng; Seshagiri R Duvvuri; Liran Zhou; Yihua Qiu; Kevin R Coombes; Nianxiang Zhang; Suk Y Yoo; Rongqing Pan; Numsen Hail; Marina Konopleva; George Calin; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta       Date:  2014-05-21

4.  Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.

Authors:  Bing Z Carter; Yi Hua Qiu; Nianxiang Zhang; Kevin R Coombes; Duncan H Mak; Deborah A Thomas; Farhad Ravandi; Hagop M Kantarjian; Erich Koller; Michael Andreeff; Steven M Kornblau
Journal:  Blood       Date:  2010-11-01       Impact factor: 22.113

5.  Poor survival with wild-type TP53 ovarian cancer?

Authors:  Kwong-Kwok Wong; Daisy I Izaguirre; Suet-Yan Kwan; Erin R King; Michael T Deavers; Anil K Sood; Samuel C Mok; David M Gershenson
Journal:  Gynecol Oncol       Date:  2013-06-22       Impact factor: 5.482

6.  Statistical Contributions to Bioinformatics: Design, Modeling, Structure Learning, and Integration.

Authors:  Jeffrey S Morris; Veerabhadran Baladandayuthapani
Journal:  Stat Modelling       Date:  2017-06-15       Impact factor: 2.039

7.  Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia.

Authors:  Steven M Kornblau; Neera Singh; YiHua Qiu; Wenjing Chen; Nianxiang Zhang; Kevin R Coombes
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

8.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

9.  Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells.

Authors:  Anil Korkut; Weiqing Wang; Emek Demir; Bülent Arman Aksoy; Xiaohong Jing; Evan J Molinelli; Özgün Babur; Debra L Bemis; Selcuk Onur Sumer; David B Solit; Christine A Pratilas; Chris Sander
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

10.  Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer.

Authors:  Ji-Yeon Yang; Henrica M J Werner; Jie Li; Shannon N Westin; Yiling Lu; Mari K Halle; Jone Trovik; Helga B Salvesen; Gordon B Mills; Han Liang
Journal:  Clin Cancer Res       Date:  2015-07-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.